特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

避妊の世界市場:製品種類別・流通チャネル別・男女別・地域別 - 市場分析、シェア、動向、規模、予測 (2020~2026年)

Contraceptive Market, By Product Types, By Distribution Channel, and By Gender, and By Geography - Analysis, Share, Trends, Size, & Forecast From 2020 - 2026

発行 AnalystView Market Insights 商品コード 941364
出版日 ページ情報 英文 216 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=106.59円で換算しております。
避妊の世界市場:製品種類別・流通チャネル別・男女別・地域別 - 市場分析、シェア、動向、規模、予測 (2020~2026年) Contraceptive Market, By Product Types, By Distribution Channel, and By Gender, and By Geography - Analysis, Share, Trends, Size, & Forecast From 2020 - 2026
出版日: 2020年05月01日 ページ情報: 英文 216 Pages
概要

世界の避妊の市場規模は、2019年には326億米ドルに達し、更に2020~2026年にかけて5.9%のCAGRで成長する見通しです。

当レポートでは、世界の避妊市場について分析し、市場の定義や基本構造、主な市場促進・抑制要因、業界の競争力・求心力、市場シェア構造、製品種類別・流通チャネル別・男女別・地域別の市場動向見通し (過去4年間・今後8年間分)、主要企業のプロファイルなどについて調査しております。

第1章 避妊市場の概要

第2章 エグゼクティブサマリー

第3章 避妊:主な市場動向

  • 市場促進要因
    • 市場促進要因の影響度の分析
  • 市場抑制要因
    • 市場抑制要因の影響度の分析
  • 市場機会
  • 将来の市場動向

第4章 避妊:産業研究

  • ポーターのファイブフォース分析
  • マーケティング戦略分析
  • 市場成長の見通し:マッピング
  • 規制体制の分析
  • 新型コロナウイルス感染症 (Covid-19) の影響の分析
    • Covid-19以前の影響分析
    • Covid-19以降の影響分析

第5章 避妊:市場環境

  • 市場シェア分析
  • 主な技術革新企業 (イノベーター)
  • 市場区分データ:主要メーカー別
    • 既存企業の分析
    • 新規企業の分析

第6章 避妊市場:製品種類別

  • 概要
    • 市場シェア分析:製品種類別 (2019年、2026年)
  • 経口避妊薬
    • 概要
    • 市場の分析・予測、対前年比成長率 (金額ベース、2015~2026年)
    • COC (複合型経口避妊薬)
    • POP (プロゲスチン単独避妊薬)
  • コンドーム
  • ダイヤフラム
  • 殺精子剤
  • 精管切除
  • スポンジ
  • 膣リング
  • 皮下インプラント
  • IUD (子宮内避妊用具)
  • 経皮パッチ
  • 注射型避妊薬

第7章 避妊市場:流通チャネル別

  • 概要
    • 市場シェア分析:流通チャネル別 (2019年、2026年)
  • 病院薬局
  • 小売薬局
  • クリニック
  • オンラインチャンネル
  • 公共機関
  • その他

第8章 避妊市場:男女別

  • 概要
    • 市場シェア分析:男女別 (2019年、2026年)
  • 男性向け
  • 女性向け

第9章 避妊市場:地域別

  • 概要
    • 市場シェア分析:地域別 (2019年、2026年)
  • 北米市場
    • 概要
    • 域内の主要メーカー
    • 市場規模とその予測:国別 (金額ベース、2015~2026年)
    • 市場規模とその予測:製品種類別 (金額ベース、2015~2026年)
    • 市場規模とその予測:流通チャネル別 (金額ベース、2015~2026年)
    • 市場規模とその予測:男女別 (金額ベース、2015~2026年)
    • 米国
    • カナダ
  • 欧州市場
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • その他の欧州諸国
  • アジア太平洋地域 (APAC) 市場
    • インド
    • 中国
    • 日本
    • 韓国
    • その他のアジア太平洋地域諸国
  • ラテンアメリカ市場
    • ブラジル
    • メキシコ
    • アルゼンチン
    • その他のラテンアメリカ諸国
  • 中東・アフリカ地域
    • サウジアラビア
    • アラブ首長国連邦 (UAE)

第10章 主要ベンダーの分析

  • Merck&Co., Inc.
    • 企業概況
    • 財務実績
    • 製品の相互比較
    • 戦略展開状況
  • Bayer AG
  • Blairex Laboratories, Inc.
  • The Cooper Companies, Inc.
  • Mayer Laboratories, Inc.
  • Mithra Pharmaceuticals
  • Afaxys, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Agile Therapeutics
  • Apothecus Pharmaceutical Corporation
  • Reckitt Benckiser Plc
  • Church & Dwight Co., Inc.
  • Allergan
  • Pfizer, Inc.

第11章 アナリストの全方位的分析

第12章 付録

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Contraceptive market: Product Type Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Contraceptive market, by Product Type 2015-2026 (USD Million)
  • TABLE Contraceptive market: Distribution Channel Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Contraceptive market, by Distribution Channel 2015-2026 (USD Million)
  • TABLE Contraceptive market: Gender Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Gender
  • TABLE Global Contraceptive market, by Gender 2015-2026 (USD Million)
  • TABLE Contraceptive market: Regional snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Contraceptive market, by Region 2015-2026 (USD Million)
  • TABLE North America Contraceptive market, by Country, 2015-2026 (USD Million)
  • TABLE North America Contraceptive market, by Product Type, 2015-2026 (USD Million)
  • TABLE North America Contraceptive market, by Distribution Channel, 2015-2026 (USD Million)
  • TABLE North America Contraceptive market, by Gender, 2015-2026 (USD Million)
  • TABLE Europe Contraceptive market, by Country, 2015-2026 (USD Million)
  • TABLE Europe Contraceptive market, by Product Type, 2015-2026 (USD Million)
  • TABLE Europe Contraceptive market, by Distribution Channel, 2015-2026 (USD Million)
  • TABLE North America Contraceptive market, by Gender, 2015-2026 (USD Million)
  • TABLE Asia Pacific Contraceptive market, by Country, 2015-2026 (USD Million)
  • TABLE Asia Pacific Contraceptive market, by Product Type, 2015-2026 (USD Million)
  • TABLE Asia Pacific Contraceptive market, by Distribution Channel, 2015-2026 (USD Million)
  • TABLE North America Contraceptive market, by Gender, 2015-2026 (USD Million)
  • TABLE Latin America Contraceptive market, by Country, 2015-2026 (USD Million)
  • TABLE Latin America Contraceptive market, by Product Type, 2015-2026 (USD Million)
  • TABLE Latin America Contraceptive market, by Distribution Channel, 2015-2026 (USD Million)
  • TABLE North America Contraceptive market, by Gender, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Contraceptive market, by Country, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Contraceptive market, by Product Type, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Contraceptive market, by Distribution Channel, 2015-2026 (USD Million)
  • TABLE North America Contraceptive market, by Gender, 2015-2026 (USD Million)

List of Figures

  • FIGURE Contraceptive market segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key Company Market Share Analysis, 2018
  • FIGURE Product Type segment market share analysis, 2019 & 2026
  • FIGURE Product Type segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Oral Contraceptive Pill market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Combined Oral Contraceptive (COC) market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Progestin-Only Contraceptive (POP) market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Condoms market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Diaphragms market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Spermicides market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Vasectomy market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Sponge market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Vaginal Ring market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Subdermal Implants market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE IUD market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Patch market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Injectable Contraception market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Distribution Channel segment market share analysis, 2019 & 2026
  • FIGURE Distribution Channel segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Hospital Pharmacy market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Retail Pharmacy market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Clinics market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Online Channels market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Public Channels market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Others market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Gender segment market share analysis, 2019 & 2026
  • FIGURE Gender segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Male market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Female market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Regional segment market share analysis, 2019 & 2026
  • FIGURE Regional segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE North America Contraceptive market share and leading players, 2018
  • FIGURE Europe Contraceptive market share and leading players, 2018
  • FIGURE Asia Pacific Contraceptive market share and leading players, 2018
  • FIGURE Latin America Contraceptive market share and leading players, 2018
  • FIGURE Middle East and Africa Contraceptive market share and leading players, 2018
  • FIGURE North America Contraceptivemarket share analysis by country, 2018
  • FIGURE U.S. Contraceptivemarket size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Canada Contraceptivemarket size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Europe Contraceptivemarket share analysis by country, 2018
  • FIGURE Germany Contraceptivemarket size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Spain Contraceptivemarket size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Italy Contraceptivemarket size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE UK Contraceptivemarket size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE FranceContraceptivemarket size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of the Europe Contraceptivemarket size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Asia Pacific Contraceptivemarket share analysis by country, 2018
  • FIGURE India Contraceptivemarket size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE China Contraceptivemarket size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Japan Contraceptivemarket size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE South Korea Contraceptivemarket size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Singapore Contraceptivemarket size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of APACContraceptivemarket size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Latin America Contraceptivemarket size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Latin AmericaContraceptivemarket share analysis by country, 2018
  • FIGURE BrazilContraceptivemarket size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Mexico Contraceptivemarket size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Argentina Contraceptivemarket size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of LATAM Contraceptivemarket size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Middle East and Africa Contraceptivemarket size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Middle East and Africa Contraceptivemarket share analysis by country, 2018
  • FIGURE Saudi Arabia Contraceptivemarket size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE United Arab Emirates Contraceptivemarket size, forecast and trend analysis, 2015 to 2026 (USD Million)
目次

REPORT HIGHLIGHT

Contraceptive market was valued at USD 32.6 billion by 2019, growing with 5.9% CAGR during the forecast period, 2020-2026

Contraceptive, also known as birth control, is a device or method used to prevent pregnancy. The aim of contraception is to allow a physical relationship without fear of an unwanted pregnancy in minimum cost and maximum comfort. The most effective ways of contraception are sterilization by means of implantable birth control, intrauterine devices (IUDs), and tubal ligation in females and vasectomy in males. Nevertheless, all the methods except sterilization are reversible, almost instantly upon discontinuing them. A sterilization method is a permanent form of birth control which is extremely effective at the regulation of fertility. As per the various research statistics, this method provides contraception for more than 250 million couples across the world.

Also, the demand for hormone-based methods such as injections, vaginal rings, patches, and oral pills is increasing at a constant rate. Other than sterilization and hormone-based therapy, there are various other emergency birth control methods such as spermicides vasectomy available commercially. These methods are used to prevent pregnancy if taken within 72 to 120 hours after unprotected sex. Furthermore, the least effective method used for birth control is physical barriers methods including fertility awareness methods, diaphragms and birth control sponges, and condoms.

Market Dynamics

The global contraceptive market growth is majorly attributed to the rising prevalence of sexually transmitted diseases (STDs). For example, according to the WHO, over 1 million STDs are acquired every day across the world. This would, in turn, fuel the demand for contraceptive products, driving the industry growth. Few of the other key drivers of the market are growing unmet contraceptive needs in developing economies, rising inclination towards planned delayed pregnancy, and favorable regulatory scenario.

Product TypeTakeaway

In terms of product types, the global contraceptive market is segmented as injectable, patch, IUD, sub-dermal implants, vaginal ring, spermicides, vasectomy, sponge, diaphragms, condoms, and pills. The condom products are further divided into male and female condoms. IUD i.e. intrauterine device is further sub-segmented as non-hormonal IUD and hormonal IUD.

Among the aforementioned product type Segmentation, the condom segment accounts for the highest value share. These products are widely used to prevent sexually transmitted infections. Furthermore, a growing preference for safe sex practices supports the segment growth to a great extent. In addition, oral contraceptive pills accounted for the significant revenue share in 2019. These products are further divided into Combined Oral Contraceptive (COC), and Progestin-Only Contraceptive (POP). COC product is considered to be the most accepted choice as over the long-acting reversible contraceptives. It includes a combination of a progestogen (progestin) and estrogen (ethinylestradiol). Nevertheless, disadvantages of pills such as migraine, nausea, amplified threat of developing STIs, and irregular bleeding may create hindrance for the segment growth. However, many research studies suggested that regular consumption of these pills reduces the threat of developing endometrial & cervical cancers, minimizes menstrual cramps, and facilitates acne reduction creates a positive impact on the segment.

Distribution Channel Takeaway

Depending upon the distribution channel, the industry is broadly classified as hospital pharmacy, retail pharmacy, clinics, online channel, and public channel. Among the above-mentioned segments, the online channel is anticipated to grow at a substantial rate over the forecast period, attributed to increasing preference for e-Commerce channel. However, due to the presence of a large number of retail pharmacies or drug stores compared to other segments, the retail pharmacy segment accounted for significantly high revenue share.

Gender Takeaway

On the basis of gender, the global contraceptive market is categorized into male and female. Among these, the male segment was accounted for dominating value share in the global market. On the other hand, the female segment is projected to expand at a substantial growth rate; owing to, increasing popularity for the product among the consumers coupled with high improvement in the product. Furthermore, in developing regions such as the Asia Pacific, the need for contraceptive products that are more women-friendly, and provide adequate privacy is increasing continuously which will support the female segment growth to a great extent.

REGIONAL TAKEAWAY

In terms of geography, the global market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Of these, North America accounted for the highest revenue share with the U.S. market is dominating the North America region. Regional growth is majorly attributed to the rising research and development activities coupled with the introduction of new products. For example, in August 2018, U.S. based pharmaceutical company, Therapeutics MD Inc., received U.S. FDA approval of ANNOVERA (EthinylEstradiol Vaginal System/Segesterone Acetate). This contraceptive product is a small, and soft flexible ring that prevents ovulation. Such introductions would, in turn, support the regional growth to a great extent. Further, Europe contraceptives market stands second in terms of value in the global market. Germany's contraceptives market accounts for a relatively high revenue share in the European market than the rest of the countries in the region. A high number of population availing sexual health services is one of the major factors bolstering the European contraceptives market.

On the other side, the Asia Pacific region is projected to grow with a promising growth rate during the study period. High population growth and rapid economic development across prominent countries are the major factors responsible for the growth of the Asia Pacific contraceptive market. India's contraceptives market is anticipated to grow at a substantial growth rate throughout the forecast period, attributed to several government initiatives, growing awareness campaigns, and rising prevalence of STDs.

KEY VENDOR TAKEAWAY

Few of the prominent market players responsible for the market trends include Pfizer, Inc., Allergan, Church & Dwight Co., Inc., Agile Therapeutics, Reckitt Benckiser Plc, Apothecus Pharmaceutical Corporation, Teva Pharmaceutical Industries Ltd., Afaxys, Inc., Mithra Pharmaceuticals, Mayer Laboratories, Inc., The Cooper Companies, Inc., Blairex Laboratories, Inc., Bayer AG, and Merck & Co., Inc.

Key market players of the global contraceptive market are focusing on increasing investments in the research and development activities through collaboration with various entities in the market environment. For instance, in January 2019, Cipla received a final nod for its Medroxyprogesterone injectable used for the prevention of pregnancy from the U.S. health regulator.

The market size and forecast for each segment and sub-segments has been considered as below:

Historical Year - 2015 to 2018

Base Year - 2019

Estimated Year - 2020

Projected Year - 2026

TARGET AUDIENCE

Traders, Distributors, and Suppliers

Manufacturers

Government and Regional Agencies

Research Organizations

Consultants

Distributors

Scope of the Report

The scope of this report covers the market by its major segments, which include as follows:

CONTRACEPTIVE MARKET KEY PLAYERS

Merck & Co., Inc.

Bayer AG

Blairex Laboratories, Inc.

The Cooper Companies, Inc.

Mayer Laboratories, Inc.

Mithra Pharmaceuticals

Afaxys, Inc.

Teva Pharmaceutical Industries Ltd.

Agile Therapeutics

Apothecus Pharmaceutical Corporation

Reckitt Benckiser Plc

Church & Dwight Co., Inc.

Allergan

Pfizer, Inc.

CONTRACEPTIVE MARKET BY PRODUCT TYPE

Oral Contraceptive Pill

Combined Oral Contraceptive (COC)

Progestin-Only Contraceptive (POP)

Condoms

Male Condoms

Female Condoms

Diaphragms

Sponge

Vaginal Ring

Spermicides

Subdermal Implants

IUD

Hormonal IUD

Nonhormonal IUD

Vasectomy

Patch

Injectable Contraception

CONTRACEPTIVE MARKET, BY DISTRIBUTION CHANNEL

Hospital Pharmacy

Retail Pharmacy

Clinics

Online Channel

Public Channel

Others

CONTRACEPTIVE MARKET, BY GENDER

Male

Female

CONTRACEPTIVE MARKET, BY REGION

North America

The U.S.

Canada

Europe

Germany

France

Italy

Spain

United Kingdom

Rest of Europe

Asia Pacific

India

China

South Korea

Japan

Singapore

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Rest of LATAM

The Middle East and Africa

Saudi Arabia

United Arab Emirates

Rest of MEA

TABLE OF CONTENT

1. CONTRACEPTIVEMARKET OVERVIEW

  • 1.1. Study Scope
  • 1.2. Assumption and Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Product Type
    • 2.1.2. Market Snippet by Distribution Channel
    • 2.1.3. Market Snippet by Gender
    • 2.1.4. Market Snippet by Region
  • 2.2. Competitive Insights

3. CONTRACEPTIVEKEY MARKET TRENDS

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. CONTRACEPTIVEINDUSTRY STUDY

  • 4.1. Porter's Five Forces Analysis
  • 4.2. Marketing Strategy Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis
  • 4.5. COVID-19 Impact Analysis
    • 4.5.1. Pre-COVID-19 Impact Analysis
    • 4.5.2. Post-COVID-19 Impact Analysis

5. CONTRACEPTIVEMARKET LANDSCAPE

  • 5.1. Market Share Analysis
  • 5.2. Key Innovators
  • 5.3. Breakdown Data, by Key manufacturer
    • 5.3.1. Established Player Analysis
    • 5.3.2. Emerging Player Analysis

6. CONTRACEPTIVE MARKET - BY PRODUCT TYPE

  • 6.1. Overview
    • 6.1.1. Segment Share Analysis, By Product Type, 2019 & 2026 (%)
  • 6.2. Oral Contraceptive Pill
    • 6.2.1. Overview
    • 6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 6.2.3. Combined Oral Contraceptive (COC)
      • 6.2.3.1. Overview
      • 6.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 6.2.4. Progestin-Only Contraceptive (POP)
      • 6.2.4.1. Overview
      • 6.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.3. Condoms
    • 6.3.1. Overview
    • 6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.4. Diaphragms
    • 6.4.1. Overview
    • 6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.5. Spermicides
    • 6.5.1. Overview
    • 6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.6. Vasectomy
    • 6.6.1. Overview
    • 6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.7. Sponge
    • 6.7.1. Overview
    • 6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.8. Vaginal Ring
    • 6.8.1. Overview
    • 6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.9. Subdermal Implants
    • 6.9.1. Overview
    • 6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.10. IUD
    • 6.10.1. Overview
    • 6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.11. Patch
    • 6.11.1. Overview
    • 6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.12. Injectable Contraception
    • 6.12.1. Overview
    • 6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

7. CONTRACEPTIVE MARKET - BY DISTRIBUTION CHANNEL

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Distribution Channel, 2019 & 2026 (%)
  • 7.2. Hospital Pharmacy
    • 7.2.1. Overview
    • 7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.3. Retail Pharmacy
    • 7.3.1. Overview
    • 7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.4. Clinics
    • 7.4.1. Overview
    • 7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.5. Online Channels
    • 7.5.1. Overview
    • 7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.6. Public Channels
    • 7.6.1. Overview
    • 7.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.7. Others
    • 7.7.1. Overview
    • 7.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

8. CONTRACEPTIVE MARKET - BY GENDER

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Distribution Channel, 2019 & 2026 (%)
  • 8.2. Male
    • 8.2.1. Overview
    • 8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.3. Female
    • 8.3.1. Overview
    • 8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

9. CONTRACEPTIVEMARKET- BY GEOGRAPHY

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product Type, 2015 - 2026 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Distribution Channel, 2015 - 2026 (US$ Million)
    • 9.2.6. North America Market Size and Forecast, By Gender, 2015 - 2026 (US$ Million)
    • 9.2.7. U.S.
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.2.8. Canada
      • 9.2.8.1. Overview
      • 9.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product Type, 2015 - 2026 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Distribution Channel, 2015 - 2026 (US$ Million)
    • 9.3.6. Europe Market Size and Forecast, By Gender, 2015 - 2026 (US$ Million)
    • 9.3.7. Germany
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.3.8. Italy
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.3.9. United Kingdom
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.3.10. France
      • 9.3.10.1. Overview
      • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.3.11. Rest of Europe
      • 9.3.11.1. Overview
      • 9.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2015 - 2026 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Distribution Channel, 2015 - 2026 (US$ Million)
    • 9.4.6. Asia Pacific Market Size and Forecast, By Gender, 2015 - 2026 (US$ Million)
    • 9.4.7. India
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.4.8. China
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.4.9. Japan
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.4.10. South Korea
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.4.11. Rest of APAC
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Product Type, 2015 - 2026 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Distribution Channel, 2015 - 2026 (US$ Million)
    • 9.5.6. Latin America Market Size and Forecast, By Gender, 2015 - 2026 (US$ Million)
    • 9.5.7. Brazil
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.5.8. Mexico
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.5.9. Argentina
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2015 - 2026 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2015 - 2026 (US$ Million)
    • 9.6.6. Middle East and Africa Market Size and Forecast, By Gender, 2015 - 2026 (US$ Million)
    • 9.6.7. Saudi Arabia
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.6.8. United Arab Emirates
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

10. KEY VENDOR ANALYSIS

  • 10.1. Merck & Co., Inc.
    • 10.1.1. Company Snapshot
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Strategic Initiatives
  • 10.2. Bayer AG
  • 10.3. Blairex Laboratories, Inc.
  • 10.4. The Cooper Companies, Inc.
  • 10.5. Mayer Laboratories, Inc.
  • 10.6. Mithra Pharmaceuticals
  • 10.7. Afaxys, Inc.
  • 10.8. Teva Pharmaceutical Industries Ltd.
  • 10.9. Agile Therapeutics
  • 10.10. Apothecus Pharmaceutical Corporation
  • 10.11. Reckitt Benckiser Plc
  • 10.12. Church & Dwight Co., Inc.
  • 10.13. Allergan
  • 10.14. Pfizer, Inc.

11. 360 DEGREE ANALYSTVIEW

12. APPENDIX

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us